Figure 1

Initial antimicrobial selection for the in-patient treatment of FN according to the ASP of the Hospital de Clínicas de Porto Alegre. *High-risk patients = MASCC score < 21 points; Low-risk patients = MASCC score ≥ 21 points. Low-risk patients were treated with intravenous antibiotics if they had one or more of the following: presence of clinical comorbidities, FN after high-dose chemotherapy, expectation of duration of neutropenia > 7 days, documented infection, clinical instability (e.g. hypotension, acute respiratory failure, acute renal failure) and gastrointestinal intolerance (e.g. severe mucositis, vomiting). ASP, antimicrobial stewardship program; FN, febrile neutropaenia; MASCC, Multinational Association for Supportive Care in Cancer.